期刊文献+

儿童新型隐球菌脑膜炎17例临床分析 被引量:11

Clinical analysis of 17 pediatric patients with cryptococcus neoformans meningitis
下载PDF
导出
摘要 目的探讨儿童新型隐球菌脑膜炎的临床特点、早期诊断和治疗方法。方法回顾性分析17例经病原学检查确诊的新型隐球菌脑膜炎临床资料。结果院外误诊15例;两性霉素B联合氟康唑治疗13例;治愈、好转7例;死亡2例。结论儿童新型隐球菌脑膜炎是以发热和颅内压增高为主要特点,反复进行脑脊液检查有助于早期诊断。两性霉素B联合氟康唑治疗新型隐球菌脑膜炎仍然安全、有效。 Objective To investigate the clinical characteristics, early diagnosis, and the methods of therapy in children with cryptococcal meningitis. Methods A retrospective analysis was performed on the clinical data of 17 patients with cryptococcal men- ingitis. Results Fifteen children with cryptococcal meningitis were misdiagnosed before admission to our hospital. Seven of 13 patients totally recovered with amphotericin B and fulconazole therapy, two of them died. Conclusion The characteristic manifestation of cryptococcal meningitis in children mainly include fever and intracranial hypertension. It is helpful to make an early diagnosis by examination of cerebrospinal fluid performed repeatedly. The analysis indicates that amphotericin B and fluconazole combination therapy remains effective and is well tolerated in the treatment of Cryptococcus meningitis.
作者 王志娇 肖农
出处 《重庆医学》 CAS CSCD 2008年第24期2824-2825,共2页 Chongqing medicine
关键词 新型隐球菌 脑膜炎 儿童 诊断 治疗 cryptococcus neoformans meningitis child ren diagnosis therapy
  • 相关文献

参考文献10

  • 1Jain N,Li Li, McFadden D C, et al. Phenotypic switching in a cryptococcus neoformans variety gattii strain is asso ciated with changes in virulence and promotes dissemination to the central nervous system[J]. Infec Immun,2006, 74(2) :896.
  • 2Guerrero A,Jain N, Goldman D L, et al. Phenotypic switching in cryptococcus neoformans[J]. Microbiology, 2006, 152(1) :3.
  • 3Charlier C, Chretien F, Baudrimont M, et al. Capsule structure changes associated with cryptocoecus neoforroans crossing of the blood brain barrier[ J]. Am J Pathol, 2005,2 : 166.
  • 4Chang Y C, Stins MF, McCaffery MJ, et ah Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood brain barrier[J]. Infect Immun,2004,72(9) :4985.
  • 5Akcaglar S, Sevgican E, Akalin H, et al. Two cases of cryptococcal meningitis in immunocompromised patients not infected with HIV[J]. Mycoses,2007,50 : 235.
  • 6Lagrou K, Van Eldere J, Keuleers S, et al. Zoonotic transmission of cryptocoeeus neoformans from a magpie to an immunocompetent patient[J]. J Intern Med, 2005,257: 385.
  • 7Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated eryptococCal meningitis:a randomised trial [J]. Lancet, 2004,363 : 1264.
  • 8Larsen RA,Bauer M, Thomas AM, et al. Amphoteriein B and fluconazole,a potent combination therapy for cryptococcal meningitis [J]. Antimicrob Agents Chemother, 2004,48 (3) : 985.
  • 9Larsen RA, Pappas PG, Perfect J, et al. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptoeoccal antibody 18137 in subjects with treated eryptoeoeeal meningitis [J]. Antimicrob Agents Chemother, 2005,49(3) :952.
  • 10Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, et al. Cryptococcosis in human immunodeficiency virus neg ative patients[J]. Int J Infect Dis, 2006,10 : 72.

同被引文献68

引证文献11

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部